321-50-6

Basic information

• Product Name: 7-FLUORO-1-H-BENZO[D][1,3]OXAZINE-2,4-DIONE
• Synonyms: 7-FLUORO-2H-3,1-BENZOXAZINE-2,4(1H)-DIONE;7-Fluoro-1H-benzo[d][1,3]oxazine-2,4-dione;2H-3,1-Benzoxazine-2,4(1H)-dione, 7-fluoro-;7-Fluoroisatoic anhydride;7-Fluoro-2H-3,1-benzoxazine-2,4(1H)-dione, 7-Fluoro-1H-benzo[d][1,3]oxazine-2,4-dione;7-fluoro-1H-3,1-benzoxazine-2,4-dione
• CAS NO: 321-50-6
• Molecular Formula: C₈H₄FNO₃
• Molecular Weight: 181.12
• Mol File: 321-50-6.mol
• Article Data: 22

Chemical Properties

• Melting Point: 229-231 °C (decomp)
• Appearance: /
• Density: 1.503 g/cm³
• Refractive Index: 1.561
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 9.91±0.20(Predicted)
• CAS DataBase Reference: 7-FLUORO-1-H-BENZO[D][1,3]OXAZINE-2,4-DIONE(CAS DataBase Reference)
• NIST Chemistry Reference: 7-FLUORO-1-H-BENZO[D][1,3]OXAZINE-2,4-DIONE(321-50-6)
• EPA Substance Registry System: 7-FLUORO-1-H-BENZO[D][1,3]OXAZINE-2,4-DIONE(321-50-6)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 321-50-6(Hazardous Substances Data)

Usage

General Description

7-FLUORO-1-H-BENZO[D][1,3]OXAZINE-2,4-DIONE is a chemical compound with the molecular formula C8H4FNO3. It is a heterocyclic compound that contains a benzoxazine ring and a dione functional group. 7-FLUORO-1-H-BENZO[D][1,3]OXAZINE-2,4-DIONE is also known as 7-Fluoro-1H-benzodioxazin-2,4-dione. It is used as a building block in organic synthesis and pharmaceutical research. This chemical has potential applications in the development of various drugs and biologically active compounds. Its properties and reactivity make it an important intermediate in the production of fine chemicals and pharmaceuticals.

InChI:InChI=1/C8H4FNO3/c9-4-1-2-5-6(3-4)10-8(12)13-7(5)11/h1-3H,(H,10,12)

Upstream product

• 324-03-8 6-fluoroisatin 
• 446-32-2 4-fluoroanthranilic acid 
• 503-38-8 trichloromethyl chloroformate 
• 32315-10-9 bis(trichloromethyl) carbonate 
• 75-44-5 phosgene 
• 399-51-9 6-fluoro-1H-indole 
• 119023-25-5 4-fluoroanthranilamide 

Downstream Products

• 76561-13-2 1-(2-amino-4-fluorophenyl)-2-methylsulfinylethanone 
• 2475-81-2 methyl 4-fluoroanthranilate 
• 620948-83-6 8-fluoro-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine 
• 76568-02-0 flosequinan 
• 76568-68-8 flosequinoxan 
• 133166-65-1 [1-(4-Bromo-2-fluoro-benzyl)-7-fluoro-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl]-acetic acid 
• 724448-75-3 2-amino-4-fluoro-benzoic acid N'-phenylacetyl-hydrazide 
• 128992-69-8 N-allyl-4-fluoroanthranilic acid 
• 97927-92-9 7-fluoro-1-methyl-2H-benzo[d][1,3]oxazine-2,4(1H)-dione 
• 917343-25-0 2-amino-4-fluoro-N-methylbenzamide 
• 1201935-93-4 2-amino-4-fluoro-N-methoxybenzamide 
• 1235480-69-9 2-amino-N-(4-sec-butyl-phenyl)-4-fluoro-benzamide 
• 1261594-19-7 3-benzyl-8-fluoro-1-methyl-3,4-dihydro-1H-benzo[d][1,3]diazepine-5(2H)-one 
• 1361967-14-7 7-fluoro-3-methyl-2-(6-(4-(trifluoromethoxy)phenyl)pyridin-3-yl)quinolin-4(1H)-one 

Relevant articles and documents

Synthesis of Ring-Fused, N-Substituted 4-Quinolinones Using p Ka-Guided, Base-Promoted Annulations with Isatoic Anhydrides: Total Synthesis of Penicinotam

An anionic annulation strategy employing isatoic anhydrides and a wide assortment of enolizable partners was developed to afford over 80 novel ring-fused, N-substituted 4-quinolinones, an underrepresented privileged template. Multiple factors governing the efficiency of the transformation were determined, resulting in a reliable and tunable synthetic platform applicable for a broad range of substrates with variable deprotonation susceptibility, such as tetramic and tetronic acids, cyclic 1,3-diketones, and cycloalkanones. Application to the synthesis of bioactive, pyrrolizine-fused 4-quinolinone, penicinotam 3, resulted in the most brief and highest yielding total synthesis of the alkaloid in three steps and a 36% overall yield.

Synthesis and nematicidal activities of 1,2,3-benzotriazin-4-one containing 4,5-dihydrothiazole-2-thiol derivatives against Meloidogyne incognita

A series of novel 1,2,3-benzotriazin-4-one derivatives containing 4,5-dihydrothiazole-2-thiol were synthesized and characterized by 1H NMR, 13C NMR, 19F NMR and HRMS. The bioassay results showed that compounds 3-(3-((4,5-dihydrothiazol-2-yl)thio)propyl)-7-methoxybenzo[d][1–3]triazin-4(3H)-one, 3-(3-((4,5-dihydrothiazol-2-yl)thio)propyl)-6-nitrobenzo[d][1–3]triazin-4(3H)-one, 7-chloro-3-(3-((4,5-dihydrothiazol-2-yl)thio)propyl)benzo[d][1–3]triazin-4(3H)-one exhibited good control efficacy against the cucumber root-knot nematode disease caused by Meloidogyne incognita at the concentration of 10.0 mg L?1 in vivo. Compound 7-chloro-3-(3-((4,5-dihydrothiazol-2-yl)thio)propyl)benzo[d][1–3]triazin-4(3H)-one showed excellent nematicidal activity with inhibition 68.3% at a concentration of 1.0 mg L?1. It suggested that the structure of 1,2,3-benzotriazin-4-one containing 4,5-dihydro-thiazole-2-thiol could be optimized further.

Target Elucidation by Cocrystal Structures of NADH-Ubiquinone Oxidoreductase of Plasmodium falciparum (PfNDH2) with Small Molecule To Eliminate Drug-Resistant Malaria

Drug-resistant malarial strains have been continuously emerging recently, which posts a great challenge for the global health. Therefore, new antimalarial drugs with novel targeting mechanisms are urgently needed for fighting drug-resistant malaria. NADH-ubiquinone oxidoreductase of Plasmodium falciparum (PfNDH2) represents a viable target for antimalarial drug development. However, the absence of structural information on PfNDH2 limited rational drug design and further development. Herein, we report high resolution crystal structures of the PfNDH2 protein for the first time in Apo-, NADH-, and RYL-552 (a new inhibitor)-bound states. The PfNDH2 inhibitor exhibits excellent potency against both drug-resistant strains in vitro and parasite-infected mice in vivo via a potential allosteric mechanism. Furthermore, it was found that the inhibitor can be used in combination with dihydroartemisinin (DHA) synergistically. These findings not only are important for malarial PfNDH2 protein-based drug development but could also have broad implications for other NDH2-containing pathogenic microorganisms such as Mycobacterium tuberculosis.